Exact Mass: 546.392

Exact Mass Matches: 546.392

Found 109 metabolites which its exact mass value is equals to given mass value 546.392, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

endo-1,4-beta-Xylanase

benzyl({3-[(4-{[3-(benzyldiethylazaniumyl)propyl]amino}-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]propyl})diethylazanium

C34H50N4O2 (546.3934)


endo-1,4-beta-Xylanase is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans. It is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans

   

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylate

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)


   

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)


   

Trioctyl trimellitate

1,2,4-Trioctyl benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)


   

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Oogoniol 1

Oogoniol 1

C33H54O6 (546.392)


   

16alpha-Acetoxybuxabenzamidienine

16alpha-Acetoxybuxabenzamidienine

C35H50N2O3 (546.3821)


   

(3R)-7,8,3,4,7,8-Hexadehydro-beta,beta-caroten-3-ol

(3R)-7,8,3,4,7,8-Hexadehydro-beta,beta-caroten-3-ol

C40H50O (546.3861)


   

Allopurpurin

(3R)-7,8-Didehydro-beta,chi-caroten-3-ol

C40H50O (546.3861)


   

Isotedaniazanthin

7,8-Didehydro-beta,phi-caroten-3-ol

C40H50O (546.3861)


   

C33H54O6

C33H54O6 (546.392)


   

25-O-methyl-FD-892

25-O-methyl-FD-892

C33H54O6 (546.392)


   

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.392)


   

hippuristerol B

hippuristerol B

C33H54O6 (546.392)


   

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

C33H54O6 (546.392)


   

crataenoside

crataenoside

C33H54O6 (546.392)


   

polystanin C

polystanin C

C33H54O6 (546.392)


   

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.392)


   

(-)-buxadienine

(-)-buxadienine

C35H50N2O3 (546.3821)


   

N-Benzoyl-O-acetylbuxodienin-E

N-Benzoyl-O-acetylbuxodienin-E

C35H50N2O3 (546.3821)


   

4-Keto-gammar-carotene

4-Keto-gammar-carotene

C40H50O (546.3861)


   

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

C33H54O6 (546.392)


   

ST 27:2;O;Hex

cholest-5,24-dien-3beta-yl beta-D-glucopyranoside

C33H54O6 (546.392)


   

Tetradehydrolycopenal

3,4,3,4-Tetradehydro-psi,psi-caroten-16-al

C40H50O (546.3861)


   

Hexadehydro-beta-caroten-3-ol

(3R)-7,8,3,4,7,8-Hexahydro-beta,beta-carotene-3-ol

C40H50O (546.3861)


   

Isotedaniaxanthin

7,8-Didehydrp-beta,phi-caroten-3-ol

C40H50O (546.3861)


   

UNII:378539Q830

Tris(2-ethylhexyl) trimellitate

C33H54O6 (546.392)


   

trioctyl benzene-1,2,4-tricarboxylate

trioctyl benzene-1,2,4-tricarboxylate

C33H54O6 (546.392)


   

Xylanase

Benzoquinonium

C34H50N4O2+2 (546.3934)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist

   

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C33H54O6 (546.392)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C33H54O6 (546.392)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C33H54O6 (546.392)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C33H54O6 (546.392)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C33H54O6 (546.392)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C33H54O6 (546.392)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

C33H54O6 (546.392)


   

2-[Carboxy-(3-octanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-octanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C29H56NO8+ (546.4006)


   

2-[Carboxy-(2-decanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-decanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C29H56NO8+ (546.4006)


   

TG(30:4)

TG(8:0_10:0_12:4)

C33H54O6 (546.392)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

AcHexZyE(0:0)

AcHexZyE(0:0)

C33H54O6 (546.392)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.392)


   

n-{1-[14-(acetyloxy)-6-(dimethylamino)-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-15-yl]ethyl}benzenecarboximidic acid

n-{1-[14-(acetyloxy)-6-(dimethylamino)-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-15-yl]ethyl}benzenecarboximidic acid

C35H50N2O3 (546.3821)


   

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.392)


   

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)


   

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)


   

(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]cyclohex-3-en-1-ol

(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]cyclohex-3-en-1-ol

C40H50O (546.3861)


   

n-[(6s,8r,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid

n-[(6s,8r,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid

C35H50N2O3 (546.3821)


   

(1s)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,6-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]cyclohex-3-en-1-ol

(1s)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,6-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]cyclohex-3-en-1-ol

C40H50O (546.3861)


   

3-{[(1r,3as,3br,5ar,7r,9ar,9br,11as)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

3-{[(1r,3as,3br,5ar,7r,9ar,9br,11as)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C33H54O6 (546.392)


   

methyl 3-[(3r,3as,4r,5ar,6s,7s,9ar,9br)-4-(acetyloxy)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[(3r,3as,4r,5ar,6s,7s,9ar,9br)-4-(acetyloxy)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)


   

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

C35H50N2O3 (546.3821)


   

5-(acetyloxy)-5-{7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate

5-(acetyloxy)-5-{7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate

C33H54O6 (546.392)


   

methyl 3-{3-[7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl}propanoate

methyl 3-{3-[7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl}propanoate

C33H54O6 (546.392)


   

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid

C35H50N2O3 (546.3821)


   

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate

C33H54O6 (546.392)


   

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.392)


   

3-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-n-heptadecyl-2-hydroxypropanimidic acid

3-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-n-heptadecyl-2-hydroxypropanimidic acid

C28H54N2O8 (546.388)


   

n-[(1s)-1-[(6s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-6-(dimethylamino)-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-15-yl]ethyl]benzenecarboximidic acid

n-[(1s)-1-[(6s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-6-(dimethylamino)-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-15-yl]ethyl]benzenecarboximidic acid

C35H50N2O3 (546.3821)


   

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methoxy-6-methylheptanoic acid

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methoxy-6-methylheptanoic acid

C33H54O6 (546.392)


   

16-(7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl)-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

16-(7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl)-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

C33H54O6 (546.392)


   

(2r)-3-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-n-heptadecyl-2-hydroxypropanimidic acid

(2r)-3-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-n-heptadecyl-2-hydroxypropanimidic acid

C28H54N2O8 (546.388)


   

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C33H54O6 (546.392)


   

methyl 22-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}docosanoate

methyl 22-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}docosanoate

C33H54O6 (546.392)


   

(3e,5e,7r,8r,9e,13e,16s)-16-[(2s,4e,7s,8r,9r,10s,11s)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

(3e,5e,7r,8r,9e,13e,16s)-16-[(2s,4e,7s,8r,9r,10s,11s)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

C33H54O6 (546.392)


   

3-({1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

3-({1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.392)


   

n-[(6s,8r,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

n-[(6s,8r,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

C35H50N2O3 (546.3821)


   

(1r,2s,3s)-1-[(1s,3's,3as,3br,5as,7r,9as,9bs,11as)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate

(1r,2s,3s)-1-[(1s,3's,3as,3br,5as,7r,9as,9bs,11as)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate

C33H54O6 (546.392)


   

3,5,5-trimethyl-4-[(9e,11e,13e,15e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]cyclohex-3-en-1-ol

3,5,5-trimethyl-4-[(9e,11e,13e,15e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]cyclohex-3-en-1-ol

C40H50O (546.3861)


   

(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]cyclohex-3-en-1-ol

(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]cyclohex-3-en-1-ol

C40H50O (546.3861)